| Year |
Citation |
Score |
| 2023 |
Nunes EJ, Addy NA, Conn PJ, Foster DJ. Targeting the Actions of Muscarinic Receptors on Dopamine Systems: New Strategies for Treating Neuropsychiatric Disorders. Annual Review of Pharmacology and Toxicology. PMID 37552895 DOI: 10.1146/annurev-pharmtox-051921-023858 |
0.313 |
|
| 2023 |
Nunes EJ, Kebede N, Haight JL, Foster DJ, Lindsley C, Conn PJ, Addy N. Ventral tegmental area M5 muscarinic receptors mediate effort-choice responding and nucleus accumbens dopamine in a sex-specific manner. The Journal of Pharmacology and Experimental Therapeutics. PMID 36828630 DOI: 10.1124/jpet.122.001438 |
0.53 |
|
| 2022 |
Nunes EJ, Kebede N, Bagdas D, Addy NA. Cholinergic and dopaminergic-mediated motivated behavior in healthy states and in substance use and mood disorders. Journal of the Experimental Analysis of Behavior. PMID 35286712 DOI: 10.1002/jeab.747 |
0.4 |
|
| 2020 |
Nunes EJ, Rupprecht LE, Foster DJ, Lindsley CW, Conn PJ, Addy NA. Examining the role of muscarinic M5 receptors in VTA cholinergic modulation of depressive-like and anxiety-related behaviors in rats. Neuropharmacology. 108089. PMID 32268153 DOI: 10.1016/J.Neuropharm.2020.108089 |
0.477 |
|
| 2019 |
Nunes EJ, Bitner L, Hughley SM, Small KM, Walton SN, Rupprecht LE, Addy NA. Cholinergic Receptor Blockade in the VTA Attenuates Cue-Induced Cocaine-Seeking and Reverses the Anxiogenic Effects of Forced Abstinence. Neuroscience. 413: 252-263. PMID 31271832 DOI: 10.1016/J.Neuroscience.2019.06.028 |
0.444 |
|
| 2018 |
Addy NA, Nunes EJ, Hughley SM, Small KM, Baracz SJ, Haight JL, Rajadhyaksha AM. The L-type calcium channel blocker, isradipine, attenuates cue-induced cocaine-seeking by enhancing dopaminergic activity in the ventral tegmental area to nucleus accumbens pathway. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29773910 DOI: 10.1038/S41386-018-0080-2 |
0.397 |
|
| 2017 |
Wickham RJ, Nunes EJ, Hughley S, Silva P, Walton SN, Park J, Addy NA. Evaluating oral flavorant effects on nicotine self-administration behavior and phasic dopamine signaling. Neuropharmacology. PMID 28943284 DOI: 10.1016/J.Neuropharm.2017.09.029 |
0.385 |
|
| 2016 |
Small KM, Nunes E, Hughley S, Addy NA. Ventral tegmental area muscarinic receptors modulate depression and anxiety-related behaviors in rats. Neuroscience Letters. 616: 80-85. PMID 26828299 DOI: 10.1016/J.Neulet.2016.01.057 |
0.534 |
|
| 2015 |
Wickham RJ, Park J, Nunes EJ, Addy NA. Examination of Rapid Dopamine Dynamics with Fast Scan Cyclic Voltammetry During Intra-oral Tastant Administration in Awake Rats. Journal of Visualized Experiments : Jove. e52468. PMID 26325447 DOI: 10.3791/52468 |
0.504 |
|
| 2015 |
Wickham RJ, Solecki WB, Nunes EJ, Addy NA. Distinct effects of ventral tegmental area NMDA and acetylcholine receptor blockade on conditioned reinforcement produced by food-associated cues. Neuroscience. 301: 384-94. PMID 26093048 DOI: 10.1016/J.Neuroscience.2015.06.021 |
0.5 |
|
| 2015 |
Addy NA, Nunes EJ, Wickham RJ. Muscarinic, but not nicotinic, acetylcholine receptor blockade in the ventral tegmental area attenuates cue-induced sucrose-seeking. Behavioural Brain Research. 291: 372-6. PMID 26026787 DOI: 10.1016/J.Bbr.2015.05.036 |
0.549 |
|
| 2015 |
Yohn SE, Santerre JL, Nunes EJ, Kozak R, Podurgiel SJ, Correa M, Salamone JD. The role of dopamine D1 receptor transmission in effort-related choice behavior: Effects of D1 agonists. Pharmacology, Biochemistry, and Behavior. 135: 217-26. PMID 26022661 DOI: 10.1016/J.Pbb.2015.05.003 |
0.562 |
|
| 2015 |
Addy NA, Nunes EJ, Wickham RJ. Ventral tegmental area cholinergic mechanisms mediate behavioral responses in the forced swim test. Behavioural Brain Research. 288: 54-62. PMID 25865152 DOI: 10.1016/J.Bbr.2015.04.002 |
0.544 |
|
| 2015 |
Wickham RJ, Park J, Nunes EJ, Addy NA. Examination of rapid dopamine dynamics with fast scan cyclic voltammetry during intra-oral tastant administration in awake rats Journal of Visualized Experiments. 2015. DOI: 10.3791/52468 |
0.316 |
|
| 2015 |
Wickham RJ, Solecki WB, Nunes EJ, Addy NA. Distinct effects of ventral tegmental area NMDA and acetylcholine receptor blockade on conditioned reinforcement produced by food-associated cues Neuroscience. 301: 384-394. DOI: 10.1016/j.neuroscience.2015.06.021 |
0.315 |
|
| 2014 |
Randall PA, Lee CA, Nunes EJ, Yohn SE, Nowak V, Khan B, Shah P, Pandit S, Vemuri VK, Makriyannis A, Baqi Y, Müller CE, Correa M, Salamone JD. The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs. Plos One. 9: e99320. PMID 24937131 DOI: 10.1371/Journal.Pone.0099320 |
0.564 |
|
| 2014 |
Nunes EJ, Randall PA, Estrada A, Epling B, Hart EE, Lee CA, Baqi Y, Müller CE, Correa M, Salamone JD. Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task. Psychopharmacology. 231: 727-36. PMID 24136220 DOI: 10.1007/S00213-013-3285-4 |
0.42 |
|
| 2013 |
Nunes EJ, Randall PA, Hart EE, Freeland C, Yohn SE, Baqi Y, Müller CE, López-Cruz L, Correa M, Salamone JD. Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 19120-30. PMID 24305809 DOI: 10.1523/Jneurosci.2730-13.2013 |
0.568 |
|
| 2013 |
Podurgiel SJ, Nunes EJ, Yohn SE, Barber J, Thompson A, Milligan M, Lee CA, López-Cruz L, Pardo M, Valverde O, Lendent C, Baqi Y, Müller CE, Correa M, Salamone JD. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor. Neuroscience. 250: 507-19. PMID 23867769 DOI: 10.1016/J.Neuroscience.2013.07.008 |
0.443 |
|
| 2013 |
Nunes EJ, Randall PA, Podurgiel S, Correa M, Salamone JD. Nucleus accumbens neurotransmission and effort-related choice behavior in food motivation: effects of drugs acting on dopamine, adenosine, and muscarinic acetylcholine receptors. Neuroscience and Biobehavioral Reviews. 37: 2015-25. PMID 23583616 DOI: 10.1016/J.Neubiorev.2013.04.002 |
0.641 |
|
| 2013 |
Salamone JD, Nunes EJ, Randall PA, Yohn SE, Merce C. S.2.1 - DEVELOPMENT OF ANIMAL MODELS OF THE EFFORT-RELATED SYMPTOMS OF DEPRESSION Behavioural Pharmacology. 24: e3. DOI: 10.1097/01.Fbp.0000434686.35248.7A |
0.31 |
|
| 2012 |
Randall PA, Pardo M, Nunes EJ, López Cruz L, Vemuri VK, Makriyannis A, Baqi Y, Müller CE, Correa M, Salamone JD. Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences. Plos One. 7: e47934. PMID 23110135 DOI: 10.1371/Journal.Pone.0047934 |
0.574 |
|
| 2012 |
Santerre JL, Nunes EJ, Kovner R, Leser CE, Randall PA, Collins-Praino LE, Lopez Cruz L, Correa M, Baqi Y, Müller CE, Salamone JD. The novel adenosine A(2A) antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions. Pharmacology, Biochemistry, and Behavior. 102: 477-87. PMID 22705392 DOI: 10.1016/J.Pbb.2012.06.009 |
0.516 |
|
| 2012 |
Salamone JD, Correa M, Nunes EJ, Randall PA, Pardo M. The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond. Journal of the Experimental Analysis of Behavior. 97: 125-46. PMID 22287808 DOI: 10.1901/Jeab.2012.97-125 |
0.586 |
|
| 2011 |
Randall PA, Nunes EJ, Janniere SL, Stopper CM, Farrar AM, Sager TN, Baqi Y, Hockemeyer J, Müller CE, Salamone JD. Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists. Psychopharmacology. 216: 173-86. PMID 21347642 DOI: 10.1007/S00213-011-2198-3 |
0.483 |
|
| 2010 |
Randall PA, Vemuri VK, Segovia KN, Torres EF, Hosmer S, Nunes EJ, Santerre JL, Makriyannis A, Salamone JD. The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior. Pharmacology, Biochemistry, and Behavior. 97: 179-84. PMID 20713079 DOI: 10.1016/J.Pbb.2010.07.021 |
0.473 |
|
| 2010 |
Nunes EJ, Randall PA, Santerre JL, Given AB, Sager TN, Correa M, Salamone JD. Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism. Neuroscience. 170: 268-80. PMID 20600675 DOI: 10.1016/J.Neuroscience.2010.05.068 |
0.578 |
|
| 2010 |
Farrar AM, Segovia KN, Randall PA, Nunes EJ, Collins LE, Stopper CM, Port RG, Hockemeyer J, Müller CE, Correa M, Salamone JD. Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors. Neuroscience. 166: 1056-67. PMID 20096336 DOI: 10.1016/J.Neuroscience.2009.12.056 |
0.602 |
|
| 2010 |
Salamone JD, Correa M, Farrar AM, Nunes EJ, Collins LE. Role of dopamine-adenosine interactions in the brain circuitry regulating effort-related decision making: Insights into pathological aspects of motivation Future Neurology. 5: 377-392. DOI: 10.2217/Fnl.10.19 |
0.54 |
|
| 2009 |
Salamone JD, Correa M, Farrar AM, Nunes EJ, Pardo M. Dopamine, behavioral economics, and effort. Frontiers in Behavioral Neuroscience. 3: 13. PMID 19826615 DOI: 10.3389/Neuro.08.013.2009 |
0.58 |
|
| 2009 |
Sink KS, Segovia KN, Nunes EJ, Collins LE, Vemuri VK, Thakur G, Makriyannis A, Salamone JD. Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats. Psychopharmacology. 206: 223-32. PMID 19588124 DOI: 10.1007/S00213-009-1602-8 |
0.531 |
|
| 2009 |
Salamone JD, Farrar AM, Font L, Patel V, Schlar DE, Nunes EJ, Collins LE, Sager TN. Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism. Behavioural Brain Research. 201: 216-22. PMID 19428636 DOI: 10.1016/J.Bbr.2009.02.021 |
0.564 |
|
| 2009 |
Mott AM, Nunes EJ, Collins LE, Port RG, Sink KS, Hockemeyer J, Müller CE, Salamone JD. The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure. Psychopharmacology. 204: 103-12. PMID 19132351 DOI: 10.1007/S00213-008-1441-Z |
0.591 |
|
| Show low-probability matches. |